Speaker 1: Bloomberg Audio Studios, podcasts, radio news. This Stock Movers report
Speaker 1: your roundup of companies making moves in the stock market,
Speaker 1: harnessing the power of Bloomberg data.
Speaker 2: Let's take a look at some stocks on the move
Speaker 2: today to a Lexus Christuffers is out front of Google
Speaker 2: this afternoon the stock movers right now, Alexis, what do
Speaker 2: you have.
Speaker 3: I've got Silicon Labs for you. This stock not like
Speaker 3: when we talk about a lot. The ticket symbol is SLAB.
Speaker 3: SLAB up fifty percent, just to give you an idea.
Speaker 3: It's based in Austin. Market cap four and a half billion,
Speaker 3: one year return last year a snoozer, basically flat. The
Speaker 3: big news today, Texas Instruments is going to buy Silicon
Speaker 3: Labs for seven and a half billion dollars. That works
Speaker 3: to about two hundred and thirty one dollars a share.
Speaker 3: Transaction expected to close in the first half of next year.
Speaker 3: And it looks like Silicon Labs investors like this deal.
Speaker 3: If you're not familiar with that, Silicon Labs chips are
Speaker 3: used and everything from smart home devices, industrial automation, battery storage,
Speaker 3: and commercial lighting. And you know Texas Instruments. I checked
Speaker 3: I mean, I guess no surprise stock is down about
Speaker 3: three percent, but last week surprisingly strong sales forecast. I
Speaker 3: think Texas Instruments is sometimes seen as a barometer, you know,
Speaker 3: of sorts from much of the economy because of its
Speaker 3: outsized role in the global supply chain. So there's your
Speaker 3: big deal of the day. And I also got to
Speaker 3: Eli Lilly.
Speaker 4: Just second to guess who advised Silicon Labs from an
Speaker 4: M and a perspective, Frank Quattrone. Oh my work, cattlest
Speaker 4: partners still getting it done on silicon.
Speaker 2: Here's to Frank, he and Mike may all worked together
Speaker 2: a few years ago in Alexis.
Speaker 3: Please all right, Eli Lilly up eight percent, absolutely obliterated.
Speaker 3: Forecast expects sales to grow as much as twenty seven
Speaker 3: percent this year. We know it's got those blockbuster weight
Speaker 3: loss drugs Munjaro zep bound. Sales more than doubled in
Speaker 3: those drugs year over year, and that's helping give it
Speaker 3: an edge over rivals like Novo Nordis, which, by the way,
Speaker 3: I want to mention down five percent said sales are
Speaker 3: going to drop as much as thirteen percent this year.
Speaker 3: If that doesn't underline, you know, price competition in the US. Also,
Speaker 3: some of its generic versions of its blockbuster drugs are
Speaker 3: coming to market, so weighing on Eli Lilly there. You
Speaker 3: know President Trump also made cutting drug costs a key
Speaker 3: priority of this administration, and we know that Eli Lilly
Speaker 3: and Novo have both struck deals to offer lower prices
Speaker 3: as a result. And I want to move over to
Speaker 3: the food space. Oh yes, now we're talking Chipotelet. I
Speaker 3: went there yesterday, a really lovely lunch on Third Avenue. Well,
Speaker 3: there's going to be very pleased that you said that,
Speaker 3: because this talk is down five percent today. I don't
Speaker 3: know about you. I used to go more often. It's
Speaker 3: been a while. I feel like it's lost its mojo.
Speaker 3: You know last year, what was it with the food?
Speaker 3: Prices have gone up and I have noticed that, but
Speaker 3: also just the for a little while they weren't giving
Speaker 3: you as much food.
Speaker 4: Well they fixed that in a big way. Yeah, oh
Speaker 4: my Nay went overboard. Now they overloaded.
Speaker 3: Give me extra chicken. So Chipotle last year's stock down
Speaker 3: thirty nine percent. They're trying to convince younger consumers, especially
Speaker 3: because that's really their bread and butter, that there's value there. Right,
Speaker 3: you got these budget conscious shoppers, where's the value? Also,
Speaker 3: believe it or not, the weight loss drugs are giving
Speaker 3: them a problem because people are consuming fewer calories and
Speaker 3: just higher prices in general. Inflation hitting them as well.
Speaker 3: They had that incident a couple of years ago, the
Speaker 3: rash of food safety concerns that sort of tarnished their image.
Speaker 3: They had a new CEO at the time. They seem
Speaker 3: to have bounced back from that, but they can't. They
Speaker 3: just cannot seem to get the traction they get the
Speaker 3: foot traffic back into the stores.
Speaker 4: At Child had great lunch there yesterday, High five and
Speaker 4: those folks breakfast.
Speaker 3: I don't think.
Speaker 2: I just think some of the Pepsi announcement I believe
Speaker 2: it was yesterday. Yeah, you know, Doritos and Cheetas and
Speaker 2: the rest. They're going to lower the price, I know. Yeah,
Speaker 2: I got to believe a Lexus they're going to lower
Speaker 2: the price but also make the portion smaller.
Speaker 3: Well, that shrink inflation, right, that's why you go and
Speaker 3: get an MBA exactly.
Speaker 1: Is yeah? Figure that out?
Speaker 2: Yeah, I mean, is that where we are in terms
Speaker 2: of affordability and purchasing.
Speaker 3: Car Well, it's a sad state of affairs if it is,
Speaker 3: but I think you're right.
Speaker 1: This stock Movers report from Bloomberg Radio. Check back with
Speaker 1: us throughout the day for the latest roundup of companies
Speaker 1: making news on Wall Street and for the latest market
Speaker 1: moving headlines. Listen to Bloomberg Radio Live, catch us on YouTube,
Speaker 1: Bloomberg dot com, and on Applecarplay and Android Auto with
Speaker 1: the Bloomberg Business app.